APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Canine Influenza Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Canine Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173974520320 December 2025183 pages

Choose your research edition.

Industry ResearchCanine Influenza Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Canine Influenza Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Canine Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Canine Influenza Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Canine Influenza Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Canine Influenza Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Canine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Canine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Canine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Canine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Canine Influenza Vaccine include Bharat Biotech, CNBG, CSL Limited, LIAONING CHENGDA, Merck Animal Health, GSK, Roche, Novartis and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Canine Influenza Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Canine Influenza Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Canine Influenza Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Canine Influenza Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Canine Influenza Vaccine Segment by Company

Bharat Biotech

CNBG

CSL Limited

LIAONING CHENGDA

Merck Animal Health

GSK

Roche

Novartis

Zoetis

Canine Influenza Vaccine Segment by Type

H3N2 Vaccine

H3N8 Vaccine

Canine Influenza Vaccine Segment by Application

Vaccination Clinic

Pet Hospital

Others

Canine Influenza Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canine Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Canine Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canine Influenza Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Canine Influenza Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Canine Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Canine Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Canine Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Canine Influenza Vaccine Industry Trends Table 2. Canine Influenza Vaccine Industry Drivers Table 3. Canine Influenza Vaccine Industry Opportunities and Challenges Table 4. Canine Influenza Vaccine Industry Restraints Table 5. Global Canine Influenza Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Canine Influenza Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Canine Influenza Vaccine Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Canine Influenza Vaccine Sales Market Share by Manufacturers Table 9. Global Canine Influenza Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Canine Influenza Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Canine Influenza Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Canine Influenza Vaccine Manufacturers, Product Type & Application Table 13. Global Canine Influenza Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Canine Influenza Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of H3N2 Vaccine Table 17. Major Manufacturers of H3N8 Vaccine Table 18. Global Canine Influenza Vaccine Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 19. Global Canine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 20. Global Canine Influenza Vaccine Sales by Type (2027-2032) & (W Units) Table 21. Global Canine Influenza Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Canine Influenza Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Canine Influenza Vaccine Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Canine Influenza Vaccine Revenue by Type (2021-2026) & (W Units) Table 25. Global Canine Influenza Vaccine Revenue by Type (2027-2032) & (W Units) Table 26. Global Canine Influenza Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Canine Influenza Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Vaccination Clinic Table 29. Major Manufacturers of Pet Hospital Table 30. Major Manufacturers of Others Table 31. Global Canine Influenza Vaccine Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Canine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 33. Global Canine Influenza Vaccine Sales by Application (2027-2032) & (W Units) Table 34. Global Canine Influenza Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Canine Influenza Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Canine Influenza Vaccine Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Canine Influenza Vaccine Revenue by Application (2021-2026) & (W Units) Table 38. Global Canine Influenza Vaccine Revenue by Application (2027-2032) & (W Units) Table 39. Global Canine Influenza Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Canine Influenza Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Canine Influenza Vaccine Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Canine Influenza Vaccine Sales by Region (2021-2026) & (W Units) Table 43. Global Canine Influenza Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Canine Influenza Vaccine Sales Forecasted by Region (2027-2032) & (W Units) Table 45. Global Canine Influenza Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Canine Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 47. North America Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 48. North America Canine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 49. Europe Canine Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 50. Europe Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 51. Europe Canine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 52. Asia Pacific Canine Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. Asia Pacific Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 54. Asia Pacific Canine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 55. South America, Middle East and Africa Canine Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. South America, Middle East and Africa Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 57. South America, Middle East and Africa Canine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 58. Global Canine Influenza Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Canine Influenza Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Canine Influenza Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Canine Influenza Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Canine Influenza Vaccine Revenue Market Share by Region (2027-2032) Table 63. Bharat Biotech Company Information Table 64. Bharat Biotech Business Overview Table 65. Bharat Biotech Canine Influenza Vaccine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Bharat Biotech Canine Influenza Vaccine Product Portfolio Table 67. Bharat Biotech Recent Development Table 68. CNBG Company Information Table 69. CNBG Business Overview Table 70. CNBG Canine Influenza Vaccine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. CNBG Canine Influenza Vaccine Product Portfolio Table 72. CNBG Recent Development Table 73. CSL Limited Company Information Table 74. CSL Limited Business Overview Table 75. CSL Limited Canine Influenza Vaccine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. CSL Limited Canine Influenza Vaccine Product Portfolio Table 77. CSL Limited Recent Development Table 78. LIAONING CHENGDA Company Information Table 79. LIAONING CHENGDA Business Overview Table 80. LIAONING CHENGDA Canine Influenza Vaccine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. LIAONING CHENGDA Canine Influenza Vaccine Product Portfolio Table 82. LIAONING CHENGDA Recent Development Table 83. Merck Animal Health Company Information Table 84. Merck Animal Health Business Overview Table 85. Merck Animal Health Canine Influenza Vaccine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Merck Animal Health Canine Influenza Vaccine Product Portfolio Table 87. Merck Animal Health Recent Development Table 88. GSK Company Information Table 89. GSK Business Overview Table 90. GSK Canine Influenza Vaccine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. GSK Canine Influenza Vaccine Product Portfolio Table 92. GSK Recent Development Table 93. Roche Company Information Table 94. Roche Business Overview Table 95. Roche Canine Influenza Vaccine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Roche Canine Influenza Vaccine Product Portfolio Table 97. Roche Recent Development Table 98. Novartis Company Information Table 99. Novartis Business Overview Table 100. Novartis Canine Influenza Vaccine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Novartis Canine Influenza Vaccine Product Portfolio Table 102. Novartis Recent Development Table 103. Zoetis Company Information Table 104. Zoetis Business Overview Table 105. Zoetis Canine Influenza Vaccine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Zoetis Canine Influenza Vaccine Product Portfolio Table 107. Zoetis Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Canine Influenza Vaccine Distributors List Table 111. Canine Influenza Vaccine Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Canine Influenza Vaccine Product Image Figure 2. Global Canine Influenza Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Canine Influenza Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Canine Influenza Vaccine Sales (2021-2032) & (W Units) Figure 5. Global Canine Influenza Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Canine Influenza Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. H3N2 Vaccine Image Figure 9. H3N8 Vaccine Image Figure 10. Global Canine Influenza Vaccine Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 11. Global Canine Influenza Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Canine Influenza Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Canine Influenza Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Canine Influenza Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Canine Influenza Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Vaccination Clinic Image Figure 17. Pet Hospital Image Figure 18. Others Image Figure 19. Global Canine Influenza Vaccine Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Canine Influenza Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Canine Influenza Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Canine Influenza Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Canine Influenza Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Canine Influenza Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 26. North America Canine Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 28. Canada Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Mexico Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Europe Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Canine Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 33. France Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 34. U.K. Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Italy Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Netherlands Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Asia Pacific Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Canine Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Japan Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 41. South Korea Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Southeast Asia Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 43. India Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Australia Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South America, Middle East and Africa Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Canine Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South Africa Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Saudi Arabia Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Turkey Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Argentina Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 52. UAE Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Egypt Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Chile Canine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Global Canine Influenza Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Canine Influenza Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Canine Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Canine Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Canine Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Canine Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Canine Influenza Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Canine Influenza Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • H3N2 Vaccine
  • H3N8 Vaccine
Applications
  • Vaccination Clinic
  • Pet Hospital
  • Others
Companies covered
  • Bharat Biotech
  • CNBG
  • CSL Limited
  • LIAONING CHENGDA
  • Merck Animal Health
  • GSK
  • Roche
  • Novartis
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Canine Influenza Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Canine Influenza Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Canine Influenza Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Canine Influenza Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Canine Influenza Vaccine Market Dynamics
  1. 2.1 Canine Influenza Vaccine Industry Trends
  2. 2.2 Canine Influenza Vaccine Industry Drivers
  3. 2.3 Canine Influenza Vaccine Industry Opportunities and Challenges
  4. 2.4 Canine Influenza Vaccine Industry Restraints
3 Canine Influenza Vaccine Market by Manufacturers
  1. 3.1 Global Canine Influenza Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Canine Influenza Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Canine Influenza Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Canine Influenza Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Canine Influenza Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Canine Influenza Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Canine Influenza Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Canine Influenza Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Canine Influenza Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Canine Influenza Vaccine Tier 1, Tier 2, and Tier 3
4 Canine Influenza Vaccine Market by Type
  1. 4.1 Canine Influenza Vaccine Type Introduction
  2. 4.1.1 H3N2 Vaccine
  3. 4.1.2 H3N8 Vaccine
  4. 4.2 Global Canine Influenza Vaccine Sales by Type
  5. 4.2.1 Global Canine Influenza Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Canine Influenza Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Canine Influenza Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Canine Influenza Vaccine Revenue by Type
  9. 4.3.1 Global Canine Influenza Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Canine Influenza Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Canine Influenza Vaccine Revenue Market Share by Type (2021-2032)
5 Canine Influenza Vaccine Market by Application
  1. 5.1 Canine Influenza Vaccine Application Introduction
  2. 5.1.1 Vaccination Clinic
  3. 5.1.2 Pet Hospital
  4. 5.1.3 Others
  5. 5.2 Global Canine Influenza Vaccine Sales by Application
  6. 5.2.1 Global Canine Influenza Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Canine Influenza Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Canine Influenza Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Canine Influenza Vaccine Revenue by Application
  10. 5.3.1 Global Canine Influenza Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Canine Influenza Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Canine Influenza Vaccine Revenue Market Share by Application (2021-2032)
6 Global Canine Influenza Vaccine Sales by Region
  1. 6.1 Global Canine Influenza Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Canine Influenza Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Canine Influenza Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Canine Influenza Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Canine Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Canine Influenza Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Canine Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Canine Influenza Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Canine Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Canine Influenza Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Canine Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Canine Influenza Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Canine Influenza Vaccine Revenue by Region
  1. 7.1 Global Canine Influenza Vaccine Revenue by Region
  2. 7.1.1 Global Canine Influenza Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Canine Influenza Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Canine Influenza Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Canine Influenza Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Canine Influenza Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Canine Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Canine Influenza Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Canine Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Canine Influenza Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Canine Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Canine Influenza Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Canine Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bharat Biotech
  2. 8.1.1 Bharat Biotech Company Information
  3. 8.1.2 Bharat Biotech Business Overview
  4. 8.1.3 Bharat Biotech Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bharat Biotech Canine Influenza Vaccine Product Portfolio
  6. 8.1.5 Bharat Biotech Recent Developments
  7. 8.2 CNBG
  8. 8.2.1 CNBG Company Information
  9. 8.2.2 CNBG Business Overview
  10. 8.2.3 CNBG Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CNBG Canine Influenza Vaccine Product Portfolio
  12. 8.2.5 CNBG Recent Developments
  13. 8.3 CSL Limited
  14. 8.3.1 CSL Limited Company Information
  15. 8.3.2 CSL Limited Business Overview
  16. 8.3.3 CSL Limited Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CSL Limited Canine Influenza Vaccine Product Portfolio
  18. 8.3.5 CSL Limited Recent Developments
  19. 8.4 LIAONING CHENGDA
  20. 8.4.1 LIAONING CHENGDA Company Information
  21. 8.4.2 LIAONING CHENGDA Business Overview
  22. 8.4.3 LIAONING CHENGDA Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 LIAONING CHENGDA Canine Influenza Vaccine Product Portfolio
  24. 8.4.5 LIAONING CHENGDA Recent Developments
  25. 8.5 Merck Animal Health
  26. 8.5.1 Merck Animal Health Company Information
  27. 8.5.2 Merck Animal Health Business Overview
  28. 8.5.3 Merck Animal Health Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Animal Health Canine Influenza Vaccine Product Portfolio
  30. 8.5.5 Merck Animal Health Recent Developments
  31. 8.6 GSK
  32. 8.6.1 GSK Company Information
  33. 8.6.2 GSK Business Overview
  34. 8.6.3 GSK Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GSK Canine Influenza Vaccine Product Portfolio
  36. 8.6.5 GSK Recent Developments
  37. 8.7 Roche
  38. 8.7.1 Roche Company Information
  39. 8.7.2 Roche Business Overview
  40. 8.7.3 Roche Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Roche Canine Influenza Vaccine Product Portfolio
  42. 8.7.5 Roche Recent Developments
  43. 8.8 Novartis
  44. 8.8.1 Novartis Company Information
  45. 8.8.2 Novartis Business Overview
  46. 8.8.3 Novartis Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novartis Canine Influenza Vaccine Product Portfolio
  48. 8.8.5 Novartis Recent Developments
  49. 8.9 Zoetis
  50. 8.9.1 Zoetis Company Information
  51. 8.9.2 Zoetis Business Overview
  52. 8.9.3 Zoetis Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zoetis Canine Influenza Vaccine Product Portfolio
  54. 8.9.5 Zoetis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Canine Influenza Vaccine Value Chain Analysis
  2. 9.1.1 Canine Influenza Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Canine Influenza Vaccine Production Mode & Process
  6. 9.2 Canine Influenza Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Canine Influenza Vaccine Distributors
  9. 9.2.3 Canine Influenza Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst